Genetic Mutation Screening in an Italian Cohort of Nonsyndromic Pheochromocytoma/Paraganglioma Patients
Base Sequence
Sequence Homology, Amino Acid
Molecular Sequence Data
Proto-Oncogene Proteins c-ret
Adrenal Gland Neoplasms
Pheochromocytoma
3. Good health
pheochromocytoma; genetics
Cohort Studies
Paraganglioma
Succinate Dehydrogenase
03 medical and health sciences
0302 clinical medicine
Italy
Von Hippel-Lindau Tumor Suppressor Protein
Mutation
pheocromocitoma
Humans
Amino Acid Sequence
DNA Primers
DOI:
10.1196/annals.1353.016
Publication Date:
2006-11-14T00:28:06Z
AUTHORS (11)
ABSTRACT
Abstract: To assess the prevalence of genetic mutations in nonsyndromic pheochromocytoma/paraganglioma (PHEO/PGL) patients we have performed a systematic search for succinate dehydrogenase (SDH) B, C, and D subunits, von Hippel–Lindau (VHL), RET genes by direct bidirectional sequencing. Patients were selected from medical records hypertension centers. After exclusion syndromic patients, 45 with familial (F+, n = 3) sporadic (F−, 42) cases isolated PHEO/PGL considered. They included 35 PHEO, 7 PGL, 3 head/neck PGL (hnPGL). Three PHEO (2F−, 1F+) presented VHL (P86A, G93C, R167W), six (4F−, 2F+) positive SDH or (SDHB R230G two SDHB S8F, R46Q, R90Q, P81L one subject each), hnPGL carried SDHD 348–351delGACT mutation. We also detected missense S163P, H50R G12S), synonymous A6A, S68S), intronic that been considered nonpathological polymorphic variants. No mutation was found SDHC genes. Our data indicate germline subunits are not infrequent as well (overall, 12 probands, 22%). Accordingly, screening such seems to be justified. However, more precise characterization functional relevance any observed sequence variant other environmental determinants neoplastic transformation is essential order plan appropriate protocols family follow‐up.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (30)
CITATIONS (20)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....